AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 33 filers reported holding AURA BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,248,913 | -27.2% | 1,031,094 | +0.3% | 0.00% | – |
Q2 2023 | $12,697,925 | +30.5% | 1,028,172 | -1.9% | 0.00% | – |
Q1 2023 | $9,730,887 | +7.3% | 1,048,587 | +21.4% | 0.00% | – |
Q4 2022 | $9,067,591 | -17.4% | 863,580 | +42.5% | 0.00% | – |
Q3 2022 | $10,978,000 | +78.0% | 605,884 | +39.2% | 0.00% | – |
Q2 2022 | $6,167,000 | +22.6% | 435,175 | +90.3% | 0.00% | – |
Q1 2022 | $5,030,000 | +30.9% | 228,633 | +1.0% | 0.00% | – |
Q4 2021 | $3,842,000 | – | 226,258 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $51,617,000 | 12.92% |
Matrix Capital Management Company, LP | 4,112,870 | $69,837,000 | 0.78% |
Rock Springs Capital Management LP | 1,008,114 | $17,118,000 | 0.40% |
Nantahala Capital Management | 99,146 | $1,683,000 | 0.06% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,255,480 | $21,318,000 | 0.04% |
Citadel Advisors | 2,315,102 | $37,318,000 | 0.01% |
CAAS CAPITAL MANAGEMENT LP | 10,000 | $170,000 | 0.00% |
Concord Wealth Partners | 150 | $3,000 | 0.00% |
Allianz Asset Management GmbH | 55,145 | $936,000 | 0.00% |
FMR LLC | 471,300 | $8,003,000 | 0.00% |